 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 May 1993 | Volume 118 Issue 10 | Pages 793-803
Purpose: To review the current state of knowledge regarding risk factors for prostate cancer.
Data Sources: Analysis of the literature through the use of MEDLINE as well as identification of papers through review of article bibliographies and the authors' personal files. Current data were also extracted from the Surveillance, Epidemiology, and End Results Program (SEER) database.
Data Selection: A review of risk factors for the development of prostate cancer. Emphasis was placed on identifying larger, controlled studies.
Data Synthesis: The clinical incidence of prostate cancer is increasing. Risk factors for prostate cancer appear to include age, race, positive family history, vasectomy, and dietary fat intake.
Conclusions: It appears that prostate cancer results from an interplay between endogenous hormones and environmental influences that include, most prominently, dietary fat.
Author and Article Information
From the Meyer L. Prentis Comprehensive Cancer Center of Metropolitan Detroit, The Wayne State University School of Medicine, Detroit, Michigan.
REVIEW
Risk Factors for Prostate Cancer
Requests for Reprints: Kenneth J. Pienta: Room 213, Michigan Cancer Foundation, 110 E. Warren, Detroit, MI 48201.
Acknowledgments: The authors thank Drs. Ray Demers, Linda Smith, and Judy Karp for their critical review and R. Demers, L. Smith, and T.Y. Kao for contribution of the metropolitan Detroit 1991 SEER data.
Grant Support: In part by the Wayne State University Fund for Medical Research and Education and through National Cancer Institute SEER contract NO1-CN-05225. Dr. Pienta is supported by Physician Scientist Award CA 60156.
This article has been cited by other articles:
|
|
 |
|
  H. Hirata, Y. Hinoda, N. Kikuno, K. Kawamoto, A. V. Dahiya, Y. Suehiro, Y. Tanaka, and R. Dahiya CXCL12 G801A Polymorphism Is a Risk Factor for Sporadic Prostate Cancer Susceptibility Clin. Cancer Res., September 1, 2007; 13(17): 5056 - 5062. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Simon, J. S. Tanzman, and J. Sabate Lack of Effect of Walnuts on Serum Levels of Prostate Specific Antigen: A Brief Report J. Am. Coll. Nutr., August 1, 2007; 26(4): 317 - 320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Nesslinger, R. A. Sahota, B. Stone, K. Johnson, N. Chima, C. King, D. Rasmussen, D. Bishop, P. S. Rennie, M. Gleave, et al. Standard Treatments Induce Antigen-Specific Immune Responses in Prostate Cancer Clin. Cancer Res., March 1, 2007; 13(5): 1493 - 1502. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Srinivasan, R. S. Ranga, R. Burikhanov, S.-S. Han, and D. Chendil Par-4-Dependent Apoptosis by the Dietary Compound Withaferin A in Prostate Cancer Cells Cancer Res., January 1, 2007; 67(1): 246 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Y. Nguyen, J. M. Major, C. J. Knott, K. M. Freeman, T. M. Downs, and G. A. Saxe Adoption of a plant-based diet by patients with recurrent prostate cancer. Integr Cancer Ther, September 1, 2006; 5(3): 214 - 223. [Abstract] [PDF]
|
|
|
|
 |
|
 H. Le, J. T. Arnold, K. K. McFann, and M. R. Blackman DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E952 - E960. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Zhang, J. Zhang, C. Y. F. Young, P. C. Kao, W. Chen, A. Jiang, L. Zhang, and Q. Guo Decoy Androgen-Responsive Element DNA Can Inhibit Androgen Receptor Transactivation of the PSA Promoter Gene Ann. Clin. Lab. Sci., January 1, 2005; 35(3): 278 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Chiao, H. Wu, G. Ramaswamy, C. C. Conaway, F.-L. Chung, L. Wang, and D. Liu Ingestion of an isothiocyanate metabolite from cruciferous vegetables inhibits growth of human prostate cancer cell xenografts by apoptosis and cell cycle arrest Carcinogenesis, August 1, 2004; 25(8): 1403 - 1408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Wu, J. W. Erdman Jr., S. J. Schwartz, E. A. Platz, M. Leitzmann, S. K. Clinton, V. DeGroff, W. C. Willett, and E. Giovannucci Plasma and Dietary Carotenoids, and the Risk of Prostate Cancer: A Nested Case-Control Study Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 260 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Rybicki, D. V. Conti, A. Moreira, M. Cicek, G. Casey, and J. S. Witte DNA Repair Gene XRCC1 and XPD Polymorphisms and Risk of Prostate Cancer Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 23 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kilkkinen, J. Virtamo, M. J. Virtanen, H. Adlercreutz, D. Albanes, and P. Pietinen Serum Enterolactone Concentration Is Not Associated with Prostate Cancer Risk in a Nested Case-Control Study Cancer Epidemiol. Biomarkers Prev., November 1, 2003; 12(11): 1209 - 1212. [Abstract] [Full Text]
|
|
|
|
|
|
S. J. Plummer, D. V. Conti, P. L. Paris, A. P. Curran, G. Casey, and J. S. Witte CYP3A4 and CYP3A5 Genotypes, Haplotypes, and Risk of Prostate Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 928 - 932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Pan, J.-S. Zhang, M. H. Gazi, and C. Y. F. Young The Cyclooxygenase 2-specific Nonsteroidal Anti-inflammatory Drugs Celecoxib and Nimesulide Inhibit Androgen Receptor Activity via Induction of c-Jun in Prostate Cancer Cells Cancer Epidemiol. Biomarkers Prev., August 1, 2003; 12(8): 769 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Wu, S. J. Schwartz, E. A. Platz, S. K. Clinton, J. W. Erdman Jr., M. G. Ferruzzi, W. C. Willett, and E. L. Giovannucci Variations in Plasma Lycopene and Specific Isomers over Time in a Cohort of U.S. Men J. Nutr., June 1, 2003; 133(6): 1930 - 1936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Saxe Integrative Tumor Board: Recently Diagnosed Prostate Cancer Integr Cancer Ther, March 1, 2003; 2(1): 65 - 73. [PDF]
|
|
|
|
 |
|
 H. Yang, J. Holcroft, B. W. Glickman, and J. G. de Boer Conjugated linoleic acid inhibits mutagenesis by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the prostate of Big Blue(R) rats Mutagenesis, March 1, 2003; 18(2): 195 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. El-Bayoumy, J. P. Richie Jr., T. Boyiri, D. Komninou, B. Prokopczyk, N. Trushin, W. Kleinman, J. Cox, B. Pittman, and S. Colosimo Influence of Selenium-enriched Yeast Supplementation on Biomarkers of Oxidative Damage and Hormone Status in Healthy Adult Males: A Clinical Pilot Study Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1459 - 1465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Makinen, T. L.J. Tammela, U.-H. Stenman, L. Maattanen, S. Rannikko, J. Aro, H. Juusela, M. Hakama, and A. Auvinen Family History and Prostate Cancer Screening With Prostate-Specific Antigen J. Clin. Oncol., June 1, 2002; 20(11): 2658 - 2663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Heber Prostate enlargement: the canary in the coal mine? Am. J. Clinical Nutrition, April 1, 2002; 75(4): 605 - 606. [Full Text] [PDF]
|
|
|
|
|
|
R. S. Taichman, C. Cooper, E. T. Keller, K. J. Pienta, N. S. Taichman, and L. K. McCauley Use of the Stromal Cell-derived Factor-1/CXCR4 Pathway in Prostate Cancer Metastasis to Bone Cancer Res., March 1, 2002; 62(6): 1832 - 1837. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Nwosu, J. Carpten, J. M. Trent, and R. Sheridan Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease Hum. Mol. Genet., October 1, 2001; 10(20): 2313 - 2318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Hoffman, F. D. Gilliland, J. W. Eley, L. C. Harlan, R. A. Stephenson, J. L. Stanford, P. C. Albertson, A. S. Hamilton, W. C. Hunt, and A. L. Potosky Racial and Ethnic Differences in Advanced-Stage Prostate Cancer: the Prostate Cancer Outcomes Study J Natl Cancer Inst, March 7, 2001; 93(5): 388 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Imaida, S. Tamano, K. Kato, Y. Ikeda, M. Asamoto, S. Takahashi, Z. Nir, M. Murakoshi, H. Nishino, and T. Shirai Lack of chemopreventive effects of lycopene and curcumin on experimental rat prostate carcinogenesis Carcinogenesis, March 1, 2001; 22(3): 467 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F Rodriguez-Artalejo, P Guallar-Castillon, J.R Banegas Banegas, J.L Gutierrez-Fisac, and J Del Rey Calero The association between mortality from ischaemic heart disease and mortality from leading chronic diseases Eur. Heart J., November 2, 2000; 21(22): 1841 - 1852. [Abstract] [PDF]
|
|
|
|
|
|
W. K. Kelly, I. Osman, V. E. Reuter, T. Curley, W. D. W. Heston, D. M. Nanus, and H. I. Scher The Development of Biologic End Points in Patients Treated with Differentiation Agents: An Experience of Retinoids in Prostate Cancer Clin. Cancer Res., March 1, 2000; 6(3): 838 - 846. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Butler, S. H. Mitchell, D. J. Tindall, and C. Y. F. Young Nonapoptotic Cell Death Associated with S-Phase Arrest of Prostate Cancer Cells via the Peroxisome Proliferator-activated Receptor {{gamma}} Ligand, 15-Deoxy-{{Delta}}12,14- prostaglandin J2 Cell Growth Differ., January 1, 2000; 11(1): 49 - 61. [Abstract] [Full Text]
|
|
|
|
|
|
J. M. Chan, M. J. Stampfer, J. Ma, E. B. Rimm, W. C. Willett, and E. L. Giovannucci Supplemental Vitamin E Intake and Prostate Cancer Risk in a Large Cohort of Men in the United States Cancer Epidemiol. Biomarkers Prev., October 1, 1999; 8(10): 893 - 899. [Abstract] [Full Text]
|
|
|
|
|
|
M. J Messina Legumes and soybeans: overview of their nutritional profiles and health effects Am. J. Clinical Nutrition, September 1, 1999; 70(3): 439S - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Giovannucci, E. B. Rimm, A. Ascherio, G. A. Colditz, D. Spiegelman, M. J. Stampfer, and W. C. Willett Smoking and Risk of Total and Fatal Prostate Cancer in United States Health Professionals1 Cancer Epidemiol. Biomarkers Prev., April 1, 1999; 8(4): 277 - 282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Mohan, A. Challa, S. Gupta, D. G. Bostwick, N. Ahmad, R. Agarwal, S. R. Marengo, S. B. Amini, F. Paras, G. T. MacLennan, et al. Overexpression of Ornithine Decarboxylase in Prostate Cancer and Prostatic Fluid in Humans Clin. Cancer Res., January 1, 1999; 5(1): 143 - 147. [Abstract] [Full Text] [PDF]
|
|
Article
